Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Dysphagia Management Market – Insights

Dysphagia is characterized by difficulty in swallowing foods or liquids. Causes of the disease include, large bites of food, inadequate chewing, dry mouth, pills, or consumption of very hot food. Dysphagia management involves use of food texture altering products and other products such as tubes to ease the process of swallowing. Although there are some drugs for the treatment of dysphagia, not all the types of the diseases are treated using drugs.

Statistics:

The global dysphagia management market is estimated to account for US$ 5,040.7 Mn in terms of value by the end of 2027.

Global Dysphagia Management Market: Drivers

Increasing geriatric population is expected to propel growth of the global dysphagia management market over the forecast period. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035.

Moreover, increasing number of people addicted to smoking is also expected to aid in growth of the market. For instance, according to the World Health Organization, 1.337 billion people smoked tobacco worldwide in 2018.

North America region held dominant position in the global dysphagia management market in 2019, accounting for 36.1% share in terms of volume, followed by Europe.

Figure 1. Global Dysphagia Management Market Share (%), by Region, 2019

Dysphagia Management  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Global Dysphagia Management Market: Restraints 

Side effects and discomfort of dysphagia drugs and tubes are expected to hamper growth of the market. Long-term use of dysphagia drugs such as proton pump inhibitors is associated with certain threats such as increased risk of hip bone fracture due to decreased absorption of calcium and iron and risk of opportunistic infections with S. pneumonia and C. defficile owing to diminished natural gut flora. Moreover, use of nasogastric tubes or PEG tubes may lead to irritation to the throat, abdominal cramping, abdominal swelling, diarrhea, nausea, vomiting, and regurgitation of food and medicines.

Moreover, difficulty in diagnosis of the exact cause of dysphagia is expected to limit growth of the market. There are many causes for dysphagia, and in some cases, it is difficult to establish the etiology of the disease.

Global Dysphagia Management Market: Opportunities

Market players can focus on launching OTC drugs for the treatment of dysphagia. For instance, majority of pharmaceutical companies in Western Europe such as Bayer AG and Johnson & Johnson are expanding into to OTC business as a contiguous out-of-pocket market.

Moreover, development of standard definitions of dysphagia and malnutrition, in-depth assessment of link between causes and outcome of dysphagia, and importance on the need for efficient and accurate screening is also expected to aid in growth of the market.

Dysphagia Management  | Coherent Market Insights

Drugs segment in the global dysphagia management market was valued at US$ 268.9 Mn in 2019 and is expected to reach US$ 403.7 Mn by 2027 at a CAGR of 5.2% during the forecast period.

Market Trends/Key Takeaways

Lack of advanced therapies for dysphagia and low awareness of the disease are major issues in developing countries. In developing countries such as India, South Africa, and Mexico, patients find difficulties procuring nutritional solutions used in the management of dysphagia. Moreover, several patient remain undiagnosed due to lack of robust medical facilities in these countries.

The prevalence of dysphagia in patients suffering from unilateral vocal fold immobility is high. For instance, according to June 2019 study in the journal Otolaryngology–Head and Neck, the prevalence of symptomatic dysphagia ranged from 55.6% to 69.0% and the aspiration rate was 20.0% to 50.0% in patients suffering from unilateral vocal fold immobility.

Segmentation

Dysphagia Management  | Coherent Market Insights

Global Dysphagia Management Market: Competitive Landscape

Major players operating in the global dysphagia management market include, Eisai Co. Ltd., C. R. Bard, Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd., Nestlé Health Science, Kent Precision Foods Group, Inc., Bracco Diagnostics Inc., Phagenesis Ltd., Nutricia Advanced Medical Nutrition, and Cook Medical Inc.

Global Dysphagia Management Market: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in January 2020, Phagenesis Ltd. received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Phagenyx System used for the treatment of neurogenic dysphagia.

In July 2019, Hormel Health Labs, a manufacturer of health and nutrition products, launched Thick & Easy Coffee Sticks, for people suffering from dysphagia.

Difficulty in swallowing foods or liquids is termed as dysphagia. Dysphagia management involves use of food texture altering products and other products such as tubes to ease the process of swallowing. Dysphagia is caused due to oral, esophageal or oropharyngeal cancer and is more common in patient suffering from stroke. Increasing prevalence of throat cancer is expected to boost growth of the global dysphagia management market over the forecast period. Furthermore, increasing number of people addicted to smoking is also anticipated to increase the number of patient suffering from dysphagia which is expected to drive the growth of the market during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Dysphagia Management market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Dysphagia Management market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Eisai Co. Ltd., C. R. Bard, Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd., Nestlé Health Science, Kent Precision Foods Group, Inc., Bracco Diagnostics Inc., Phagenesis Ltd., Nutricia Advanced Medical Nutrition, and Cook Medical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Dysphagia Management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Dysphagia Management market

Detailed Segmentation:

  • Dysphagia Management Market, By Product:
    • Drugs
      • Proton Pump Inhibitors
    • Feeding Tubes
      • Naso-Gastric Tubes
      • PEG tubes
    • Nutritional Solutions
      • Thickeners
      • Beverages
      • Purees
  • Dysphagia Management Market, By Indication:
    • Oropharangeal Dysphagia
    • Esophageal Dysphagia
  • Dysphagia Management Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • Specialty Clinics 
  • Dysphagia Management Market, By Region:
    • North America
      • By Product:
        • Drugs
          • Proton Pump Inhibitors
        • Feeding Tubes
          • Naso-Gastric Tubes
          • PEG tubes
        • Nutritional Solutions
          • Thickeners
          • Beverages
          • Purees
      • By Indication
        • Oropharangeal Dysphagia
        • Esophageal Dysphagia
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Drug Stores
        • Specialty Clinics
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product:
        • Drugs
          • Proton Pump Inhibitors
        • Feeding Tubes
          • Naso-Gastric Tubes
          • PEG tubes
        • Nutritional Solutions
          • Thickeners
          • Beverages
          • Purees
      • By Indication
        • Oropharangeal Dysphagia
        • Esophageal Dysphagia
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Drug Stores
        • Specialty Clinics
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product:
        • Drugs
          • Proton Pump Inhibitors
        • Feeding Tubes
          • Naso-Gastric Tubes
          • PEG tubes
        • Nutritional Solutions
          • Thickeners
          • Beverages
          • Purees
      • By Indication
        • Oropharangeal Dysphagia
        • Esophageal Dysphagia
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Drug Stores
        • Specialty Clinics
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product:
        • Drugs
          • Proton Pump Inhibitors
        • Feeding Tubes
          • Naso-Gastric Tubes
          • PEG tubes
        • Nutritional Solutions
          • Thickeners
          • Beverages
          • Purees
      • By Indication
        • Oropharangeal Dysphagia
        • Esophageal Dysphagia
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Drug Stores
        • Specialty Clinics
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product:
        • Drugs
          • Proton Pump Inhibitors
        • Feeding Tubes
          • Naso-Gastric Tubes
          • PEG tubes
        • Nutritional Solutions
          • Thickeners
          • Beverages
          • Purees
      • By Indication
        • Oropharangeal Dysphagia
        • Esophageal Dysphagia
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Drug Stores
        • Specialty Clinics
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product:
        • Drugs
          • Proton Pump Inhibitors
        • Feeding Tubes
          • Naso-Gastric Tubes
          • PEG tubes
        • Nutritional Solutions
          • Thickeners
          • Beverages
          • Purees
      • By Indication
        • Oropharangeal Dysphagia
        • Esophageal Dysphagia
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Drug Stores
        • Specialty Clinics
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Eisai Co. Ltd. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • C. R. Bard, Inc. (Becton, Dickinson and Company)
    • Hormel Health Labs
    • AstraZeneca
    • Cipla Ltd.
    • Nestlé Health Science
    • Kent Precision Foods Group, Inc.
    • Bracco Diagnostics Inc.
    • Phagenesis Ltd.
    • Nutricia Advanced Medical Nutrition
    • Cook Medical Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Dysphagia Management Market, By Product, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Proton Pump Inhibitors
    • Feeding Tubes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Naso-Gastric Tubes
        • PEG tubes
    • Nutritional Solutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Thickeners
        • Beverages
        • Purees
  5. Global Dysphagia Management Market, By Indication, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Oropharangeal Dysphagia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Esophageal Dysphagia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Dysphagia Management Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Stores
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Dysphagia Management Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • Eisai Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • C. R. Bard, Inc. (Becton, Dickinson and Company)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hormel Health Labs
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AstraZeneca
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cipla Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nestlé Health Science
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kent Precision Foods Group, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bracco Diagnostics Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Phagenesis Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nutricia Advanced Medical Nutrition
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cook Medical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 16 figures on “Dysphagia Management Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner